Immediate Impact
9 from Science/Nature 99 standout
Citing Papers
Cefepime–Taniborbactam in Complicated Urinary Tract Infection
2024 Standout
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
2024 Standout
Works of Bartolomé Moyá being referenced
WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 Showing Potent “β-Lactam Enhancer” Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones
2017
Pseudomonas aeruginosa Ceftolozane-Tazobactam Resistance Development Requires Multiple Mutations Leading to Overexpression and Structural Modification of AmpC
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Bartolomé Moyá | 2624 | 1032 | 1294 | 51 | 3.1k | |
| Gabriel Cabot | 2531 | 928 | 1401 | 57 | 3.0k | |
| Laura Zamorano | 2243 | 905 | 1192 | 66 | 2.8k | |
| Patrick Plésiat | 2728 | 782 | 1824 | 96 | 4.0k | |
| Alejandro Beceiro | 2662 | 774 | 1331 | 90 | 3.7k | |
| Antonio Doménech‐Sánchez | 2491 | 724 | 781 | 45 | 3.0k | |
| José Manuel Rodríguez-Martínez | 2779 | 998 | 879 | 94 | 3.3k | |
| Philip Lister | 1646 | 837 | 954 | 41 | 2.5k | |
| B. Wiedemann | 2104 | 836 | 957 | 154 | 3.6k | |
| Antonio Oliver | 1730 | 635 | 942 | 39 | 2.1k | |
| Y. Arakawa | 2437 | 551 | 1179 | 41 | 3.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...